Download Free Sample Report

Alzheimer Disease DNA Test Market, Global Outlook and Forecast 2024-2030

Alzheimer Disease DNA Test Market, Global Outlook and Forecast 2024-2030

  • Published on : 19 July 2024
  • Pages :69
  • Report Code:SMR-7972379

Download Report PDF Instantly

Leave This Empty:

Secure

Report overview

The global Alzheimer Disease DNA Test market was valued at US$ 115.2 million in 2023 and is projected to reach US$ 358.7 million by 2030, at a CAGR of 17.6% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

The global key manufacturers of Alzheimer Disease DNA Test include 23andMe, LabCorp, Empower DX, Mega Genomics, Blueprint Genetics, Generi-Biotech, RxHomeTest, Kashi Labs and SolGent, etc. in 2023, the global top five players have a share approximately % in terms of revenue.
Alzheimer's disease is a complex and multifactorial disorder with both genetic and environmental factors contributing to its development. While there are genetic tests available for Alzheimer's disease, these tests are primarily used for research purposes and are not routinely used in clinical practice.
This report aims to provide a comprehensive presentation of the global market for Alzheimer Disease DNA Test, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Alzheimer Disease DNA Test. This report contains market size and forecasts of Alzheimer Disease DNA Test in global, including the following market information:

  • Global Alzheimer Disease DNA Test Market Revenue, 2019-2024, 2025-2030, ($ millions)
  • Global top five companies in 2023 (%)

We surveyed the Alzheimer Disease DNA Test companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Alzheimer Disease DNA Test Market, by Type, 2019-2024, 2025-2030 ($ millions)
Global Alzheimer Disease DNA Test Market Segment Percentages, by Type, 2023 (%)

  • Blood Sample
  • Saliva Sample
Global Alzheimer Disease DNA Test Market, by Application, 2019-2024, 2025-2030 ($ millions)
Global Alzheimer Disease DNA Test Market Segment Percentages, by Application, 2023 (%)
  • Online
  • Offline
Global Alzheimer Disease DNA Test Market, By Region and Country, 2019-2024, 2025-2030 ($ Millions)
Global Alzheimer Disease DNA Test Market Segment Percentages, By Region and Country, 2023 (%)
  • North America
  • US
  • Canada
  • Mexico
  • Europe
  • Germany
  • France
  • U.K.
  • Italy
  • Russia
  • Nordic Countries
  • Benelux
  • Rest of Europe
  • Asia
  • China
  • Japan
  • South Korea
  • Southeast Asia
  • India
  • Rest of Asia
  • South America
  • Brazil
  • Argentina
  • Rest of South America
  • Middle East & Africa
  • Turkey
  • Israel
  • Saudi Arabia
  • UAE
  • Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
  • Key companies Alzheimer Disease DNA Test revenues in global market, 2019-2024 (estimated), ($ millions)
  • Key companies Alzheimer Disease DNA Test revenues share in global market, 2023 (%)
Key players include:
  • 23andMe
  • LabCorp
  • Empower DX
  • Mega Genomics
  • Blueprint Genetics
  • Generi-Biotech
  • RxHomeTest
  • Kashi Labs
  • SolGent
  • CapitalBio
  • Genex Diagnostics
  • Sansure

Outline of Major Chapters:
Chapter 1: Introduces the definition of Alzheimer Disease DNA Test, market overview.
Chapter 2: Global Alzheimer Disease DNA Test market size in revenue.
Chapter 3: Detailed analysis of Alzheimer Disease DNA Test company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Alzheimer Disease DNA Test in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.